Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Endo

Showing results (221-230 of 445) with videos related to

Pageof 45
Sort By:
Lipids|February 21, 1998
Enhancement of low density lipoprotein binding to both low density lipoprotein receptor-positive and -negative cells by tetracycline antibioticsS Miura, K Hasumi, R Takayasu, et al.
The British Journal of Surgery|July 13, 2018
Outcomes of patients receiving a massive transfusion for major traumaA Endo, A Shiraishi, K Fushimi, et al.
The Journal of Antibiotics|July 1, 1991
Pannorin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor produced by Chrysosporium pannorumH Ogawa, K Hasumi, K Sakai, et al.
The Journal of Antibiotics|May 27, 1999
11-Keto-9(E),12(E)-octadecadienoic acid, a novel fatty acid that enhances fibrinolytic activity of endothelial cellsC Shinohara, K Hasumi, T Chikanishi, et al.
Biochimica Et Biophysica Acta|June 5, 1992
Inhibition of the accumulation of lipid droplets in macrophage J774 by bafilomycin B1 and destruxin ES Naganuma, N Kuzuya, K Sakai, et al.
Health Physics|April 1, 1992
Development of a chemical form discrimination system for 14C species in gaseous wasteA Endo, T Matsui, T Ohnuki, et al.
Atherosclerosis|March 1, 1979
Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseY Tsujita, M Kuroda, K Tanzawa, et al.
Applied Optics|March 22, 2008
Laser microprobe and resonant laser ablation for depth profile measurements of hydrogen isotope atoms contained in graphiteM Yorozu, T Yanagida, T Nakajyo, et al.
The Journal of Antibiotics|December 1, 1990
Isolation and biosynthesis of 3 alpha-hydroxy-3,5-dihydromonacolin LT Nakamura, D Komagata, S Murakawa, et al.
International Journal of Hematology|February 1, 1997
Clinical significance of serum soluble interleukin-2 receptor in chronic myeloproliferative disordersT Kawatani, A Endo, F Tajima, et al.
Pageof 45

Showing results (221-230 of 445) with videos related to

Sort By:
Pageof 45
Lipids|February 21, 1998
Enhancement of low density lipoprotein binding to both low density lipoprotein receptor-positive and -negative cells by tetracycline antibioticsS Miura, K Hasumi, R Takayasu, et al.
The British Journal of Surgery|July 13, 2018
Outcomes of patients receiving a massive transfusion for major traumaA Endo, A Shiraishi, K Fushimi, et al.
The Journal of Antibiotics|July 1, 1991
Pannorin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor produced by Chrysosporium pannorumH Ogawa, K Hasumi, K Sakai, et al.
The Journal of Antibiotics|May 27, 1999
11-Keto-9(E),12(E)-octadecadienoic acid, a novel fatty acid that enhances fibrinolytic activity of endothelial cellsC Shinohara, K Hasumi, T Chikanishi, et al.
Biochimica Et Biophysica Acta|June 5, 1992
Inhibition of the accumulation of lipid droplets in macrophage J774 by bafilomycin B1 and destruxin ES Naganuma, N Kuzuya, K Sakai, et al.
Health Physics|April 1, 1992
Development of a chemical form discrimination system for 14C species in gaseous wasteA Endo, T Matsui, T Ohnuki, et al.
Atherosclerosis|March 1, 1979
Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseY Tsujita, M Kuroda, K Tanzawa, et al.
Applied Optics|March 22, 2008
Laser microprobe and resonant laser ablation for depth profile measurements of hydrogen isotope atoms contained in graphiteM Yorozu, T Yanagida, T Nakajyo, et al.
The Journal of Antibiotics|December 1, 1990
Isolation and biosynthesis of 3 alpha-hydroxy-3,5-dihydromonacolin LT Nakamura, D Komagata, S Murakawa, et al.
International Journal of Hematology|February 1, 1997
Clinical significance of serum soluble interleukin-2 receptor in chronic myeloproliferative disordersT Kawatani, A Endo, F Tajima, et al.
Pageof 45